Cardinal Health Inc. [NYSE: CAH] price surged by 5.18 percent to reach at $3.25. The company report on August 11, 2022 that Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2022.
China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal
Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.
Simply click here and the name & trading symbol are yours.
Revenue increased 11% to $47.1 billion in the fourth quarter.
GAAP1 operating earnings were $36 million in the fourth quarter; GAAP diluted EPS were $0.50 in the fourth quarter.
A sum of 6861412 shares traded at recent session while its average daily volume was at 2.27M shares. Cardinal Health Inc. shares reached a high of $66.20 and dropped to a low of $60.525 until finishing in the latest session at $66.00.
The one-year CAH stock forecast points to a potential downside of -10.0. The average equity rating for CAH stock is currently 2.80, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Cardinal Health Inc. [CAH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CAH shares is $60.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CAH stock is a recommendation set at 2.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Barclays have made an estimate for Cardinal Health Inc. shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on May 26, 2022. While these analysts kept the previous recommendation, Evercore ISI raised their target price from $55 to $68. The new note on the price target was released on May 18, 2022, representing the official price target for Cardinal Health Inc. stock. Previously, the target price had yet another raise to $74, while Morgan Stanley analysts kept a Overweight rating on CAH stock.
The Average True Range (ATR) for Cardinal Health Inc. is set at 1.45, with the Price to Sales ratio for CAH stock in the period of the last 12 months amounting to 0.10.
CAH Stock Performance Analysis:
Cardinal Health Inc. [CAH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.56. With this latest performance, CAH shares gained by 24.76% in over the last four-week period, additionally plugging by 22.29% over the last 6 months – not to mention a rise of 27.68% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CAH stock in for the last two-week period is set at 87.23, with the RSI for the last a single of trading hit 93.40, and the three-weeks RSI is set at 80.30 for Cardinal Health Inc. [CAH]. The present Moving Average for the last 50 days of trading for this stock 55.37, while it was recorded at 62.70 for the last single week of trading, and 54.05 for the last 200 days.
Insight into Cardinal Health Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Cardinal Health Inc. [CAH] shares currently have an operating margin of +1.12 and a Gross Margin at +3.91. Cardinal Health Inc.’s Net Margin is presently recorded at +0.38.
Return on Total Capital for CAH is now 20.74, given the latest momentum, and Return on Invested Capital for the company is 7.44. Return on Equity for this stock inclined to 34.13, with Return on Assets sitting at 1.43. When it comes to the capital structure of this company, Cardinal Health Inc. [CAH] has a Total Debt to Total Equity ratio set at 374.93. Additionally, CAH Total Debt to Total Capital is recorded at 78.94, with Total Debt to Total Assets ending up at 15.11. Long-Term Debt to Equity for the company is recorded at 320.44, with the Long-Term Debt to Total Capital now at 67.47.
Reflecting on the efficiency of the workforce at the company, Cardinal Health Inc. [CAH] managed to generate an average of $12,918 per employee. Receivables Turnover for the company is 18.69 with a Total Asset Turnover recorded at a value of 3.81.Cardinal Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.50 and a Current Ratio set at 1.10.
CAH Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CAH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Cardinal Health Inc. go to 3.62%.
Cardinal Health Inc. [CAH] Insider Position Details
There are presently around $15,692 million, or 89.50% of CAH stock, in the hands of institutional investors. The top three institutional holders of CAH stocks are: VANGUARD GROUP INC with ownership of 33,735,900, which is approximately -5.875% of the company’s market cap and around 0.30% of the total institutional ownership; BLACKROCK INC., holding 23,108,919 shares of the stock with an approximate value of $1.53 billion in CAH stocks shares; and STATE STREET CORP, currently with $1.44 billion in CAH stock with ownership of nearly 2.145% of the company’s market capitalization.
Positions in Cardinal Health Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 365 institutional holders increased their position in Cardinal Health Inc. [NYSE:CAH] by around 21,757,739 shares. Additionally, 369 investors decreased positions by around 18,892,531 shares, while 131 investors held positions by with 197,105,894 shares. The mentioned changes placed institutional holdings at 237,756,164 shares, according to the latest SEC report filing. CAH stock had 77 new institutional investments in for a total of 5,285,749 shares, while 81 institutional investors sold positions of 2,759,789 shares during the same period.